Clinical Trials
3 trialsNCT05251727 2024-08-19
Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients
Veloxis Pharmaceuticals
Phase 1 Terminated
NCT05593614 2024-07-16
ACT
AlgoTherapeutix
Phase 2 Active not recruiting
NCT04282590 2022-03-15
A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)
Toray Industries, Inc
Phase 2 Withdrawn